Table of Contents

1 Report Prologue
1.1 Introduction
2 Introduction
2.1 Research Objective
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.4.1 Trade Analysis
3.4.2 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence and incidence of diabetes mellitus (DM) (Impact Weightage-35%)
4.2.2 Rise in technological innovations (Impact Weightage-30%)
4.2.3 Research funding in diabetes diagnosis and treatment (Impact Weightage-15%)
4.2.4 Rising awareness and screening for Diabetes Mellitus (Impact Weightage-20%)
4.3 Restraints
4.3.1 Stringent reimbursement and insurance policies in developing nations, can hamper the market growth in coming future (Impact Weightage-35%)
4.3.2 High cost associated with diagnosis and treatment of diabetes (Impact Weightage-65%?)
4.4 Opportunities
4.4.1 Technologically advanced products in the pipeline
4.4.2 Rise in Global Obesity Population
4.4.3 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Raw Material
5.2.2 Supplier
5.2.3 Manufacturer
5.2.4 Distributer
5.2.5 Customer
5.2.6 Consumer
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Diabetes Monitors Market by Sample
6.1 Introduction
6.2 Blood Samples
6.3 Sweat Samples
6.4 Urine Samples
6.5 Others
7 Global Diabetes Monitors Market by Type
7.1 Introduction
7.2 Point sample test based Glucose Monitors
7.3 Continuous glucose monitors
7.4 Enzyme free sensor based Glucose Monitors
8 Global Diabetes Monitors Market by Components
8.1 Introduction
8.2 Lancet
8.3 Glucose test strips
8.4 Sensors
9 Global Diabetes Monitors Market by End Users
9.1 Introduction
9.2 Diagnostic Clinics
9.3 Hospitals
9.4 Home
10 Global Diabetes Monitors Market by Regions
10.1 Introduction
10.2 Americas
10.2.1 US
10.2.2 Canada
10.2.3 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 UAE
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of Middle East & Africa
11 Competitive Landscape
11.1 Introduction
12 Company Profiles
12.1 Panasonic
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products
12.1.4 Strategy
12.1.5 Key Developments
12.2 Abbott Laboratories
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products
12.2.4 Strategy
12.2.5 Key Developments
12.3 Dexcom, Inc.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products
12.3.4 Strategy
12.3.5 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products
12.4.4 Strategy
12.4.5 Key Developments
12.5 LifeScan, Inc.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products
12.5.4 Strategy
12.5.5 Key Developments
12.6 Sanofi
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products
12.6.4 Strategy
12.6.5 Key Developments
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO's View Point
13.2 Key companies to watch
14 Appendix
14.1 Discussion Blue Print